StockTipsArenaBeta

BUY Aurobindo Pharma — Pradip Hotchandani, Prudent Corporate Advisory Services

BUYAurobindo Pharma
Aurobindo Pharma share price target & all analyst calls

byPradip Hotchandani, Prudent Corporate Advisory ServicesHorizon: NA (inferred Swing (≤2wk))30 Mar 2026via CNBC Awaaz.

Entry₹1,315Stated
Target₹1,380
Total upside +4.94% (call closed)
Stop loss₹1,273-3.19% risk
Exit₹1,2732 Apr 2026, 9:45 am
Stop-loss hit-3.19%
Follow Pradip Hotchandani for new calls(20% target hit, 41 closed calls)Get alertsWatch AUROPHARMA for new buy/sell callsGet alertsSee 1 active Swing call on AUROPHARMA

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 2 Apr 2026
1 supporting0 opposing
Supports the BUY call (1)

1 advisor has an active short-term BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·1 Apr · today

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Aurobindo Pharma

All analyst calls on Aurobindo Pharma

More from Pradip Hotchandani, Prudent Corporate Advisory Services

Every call and its outcome